Page 108- Extracorporeal photopheresis with the dendritic cell vaccine, (FDA approved
for cutaneous T cell lymphoma due to the research by Richard L. Edelson, Yale
University,) works in the following way:
Via the photopheresis apparatus pathologic immune complexes can be removed
from the blood and a certain quantity of blood is exposed to a controlled amount
of ultraviolet energy, which has an enormous immune boosting effect. During this
procedure dendritic cells can be collected and separately cultured to maturity and
re-infunded into the patient’s vein.
Dendritic cells are responsible for identifying pathogens (viruses, fungi, bacteria,
malignant cells) and presenting their identifying markers, antigens, to key
lymphocytes that then multiply and attack the disease.
Photopheresis induces monocytes to transform into dendritic cells, thereby
greatly increasing their numbers. By centrifuging blood in a cell separator
and passing the white cells through the ultraviolet light chamber, millions of
monocytes are converted into dendritic cells. By culturing them with growth
factors, these cells can learn to ingest and process pathogens that formerly
eluded the immune system. Thus, when they are re-introduced to the body, they
awaken sleeping immunities.
- Nutritional immunotherapy, blood oxygenation, glandulars, bontanicals, enzyme
therapy aid cellular metabolism, tissue and organ function.
The Issels Treatment has demonstrated the longest and most successful track
record in cancer immunotherapy history.